Rasmus Münter is a PhD student from the Technical University of Denmark, doing a project entitled the "Protein Corona of Liposomes for Drug Delivery". Rasmus received his masters degree in Nanoscience from University of Copenhagen (Denmark) and University of Queensland (Australia) in 2016, specializing in nanobioscience, biophysics and nanomedicine. Since then, he has worked in Thomas Andresen’s group at the Technical University of Denmark, where he has been engaged in development of lipid nanoparticles for cancer immunotherapy. Besides design of liposomal formulations, his specialties lie within single liposome assays for characterization of protein/membrane interactions and immunogenic responses against lipid nanoparticles.